Tomasz Mach

Prof. Tomasz Mach

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
AMAgnieszka Mazur-Bialy
Agnieszka Mazur-Bialy
Jan BilskiJan Bilski
Jan Bilski
DWDagmara Wójcik
Dagmara Wójcik
BBBartosz Brzozowski
Bartosz Brzozowski
MSMarcin Surmiak
Marcin Surmiak
Tomasz BrzozowskiTomasz Brzozowski
Tomasz Brzozowski
Inflammatory bowel diseases (IBDs) are a heterogeneous group of disorders exhibited by two major phenotypic forms: Crohn‘s disease and ulcerative colitis. Although the aetiology of IBD is unknown, several factors coming from the adipose tissue and skeletal muscles, such as cytokines, adipokines and myokines, were suggested in the pathogenesis of ulcerative colitis; however, it has not been extensively studied whether voluntary exercise can ameliorate that disorder. We explored the effect of moderate exercise (i.e., voluntary wheel running) on the disease activity index (DAI), colonic blood flow (CBF), plasma irisin and adiponectin levels and real-time PCR expression of proinflammatory markers in mesenteric fat in mice with 2,4,6-trinitrobenzenesulfonic acid (TNBS) colitis fed a high-fat diet (HFD) compared to those on a standard chow diet (SD). Macroscopic and microscopic colitis in sedentary SD mice was accompanied by a significant fall in CBF, some increase in colonic tissue weight and a significant increase in the plasma levels of tumour necrosis factor-alpha (TNF-α), IL-6, monocyte chemotactic protein 1 (MCP-1) and IL-13 (p < 0.05). In sedentary HFD mice, colonic lesions were aggravated, colonic tissue weight increased and the plasma TNF-α, IL-6, MCP-1, IL-1β and leptin levels significantly increased. Simultaneously, a significant decrease in the plasma irisin and adiponectin levels was observed in comparison with SD mice (p < 0.05). Exercise significantly decreased macroscopic and microscopic colitis, substantially increased CBF and attenuated the plasma TNF-α, IL-6, MCP-1, IL-1β and leptin levels while raising the plasma irisin and the plasma and WAT concentrations of adiponectin in HFD mice (p < 0.05). We conclude that: (1) experimental colitis is exacerbated in HFD mice, possibly due to a fall in colonic microcirculation and an increase in the plasma and mesenteric fat content of proinflammatory biomarkers; and (2) voluntary physical activity can attenuate the severity of colonic damage in mice fed a HFD through the release of protective irisin and restoration of plasma adiponectin.

13 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OKOlga Kaczmarczyk
Olga Kaczmarczyk
ADAgnieszka Dąbek-Drobny
Agnieszka Dąbek-Drobny
Michal WozniakiewiczMichal Wozniakiewicz
Michal Wozniakiewicz
PPPaweł Paśko
Paweł Paśko
JDJustyna Dobrowolska-Iwanek
Justyna Dobrowolska-Iwanek
Malgorzata Zwolinska-WcisloMalgorzata Zwolinska-Wcislo
Malgorzata Zwolinska-Wcislo
Intestinal dysbiosis plays a crucial role in the development of inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). The importance of bacterial metabolites, such as short-chain fatty acids (SCFAs), succinic and lactic acids, as well as environmental factors that affect their production in the course of IBD, remains unclear. The aim of this study was to evaluate a profile of organic acids in the stool of CD and UC patients with different disease activity. We assessed a correlation between used medications, patient’s diet, and SCFA levels. A total of 35 adult patients were included in the study. We did not observe significant differences in the levels of organic acids between the CD and UC groups, irrespective of disease activity, and a control group. However, propionic acid levels were higher in IBD patients who received trimebutine vs. those who did not (p = 0.031). Higher isobutyric acid levels were observed in patients treated with biological drugs compared with those without such treatment (p = 0.014). No significant correlations were found between organic acid levels and the frequency of dietary fiber consumption. Our results reveal a new link between medication use and organic acid levels in patients with IBD.

6 January 2017 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
APAgnieszka Paziewska
Agnieszka Paziewska
AHAndrzej Habior
Andrzej Habior
ARAgnieszka Rogowska
Agnieszka Rogowska
WZWłodzimierz Zych
Włodzimierz Zych
KGKrzysztof Goryca
Krzysztof Goryca
JOJerzy Ostrowski
Jerzy Ostrowski
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are forms of hepatic autoimmunity, and risk for both diseases has a strong genetic component. This study aimed to define the genetic architecture of PBC and PSC within the Polish population. Subjects were 443 women with PBC, 120 patients with PSC, and 934 healthy controls recruited from Gastroenterology Departments in various Polish hospitals. Allelotyping employed a pooled-DNA sample-based genome-wide association study (GWAS) approach, using Illumina Human Omni2.5-Exome BeadChips and the following novel selection criteria for risk loci: blocks of at least 10 single nucleotide polymorphisms (SNPs) in strong linkage disequilibrium, where the distance between each adjacent SNP pair in the block was less than 30 kb, and each SNP was associated with disease at a significance level of P < 0.005. A selected index SNP from each block was validated using TaqMan SNP genotyping assays. Nineteen and twenty-one SNPs were verified as associated with PBC and PSC, respectively, by individual genotyping; 19 (10/9, PBC/PSC) SNPs reached a stringent (corrected) significance threshold and a further 21 (9/12, PBC/PSC) reached a nominal level of significance (P < 0.05 with odds ratio (OR) > 1.2 or < 0.83), providing suggestive evidence of association. The SNPs mapped to seven (1p31.3, 3q13, 6p21, 7q32.1, 11q23.3, 17q12, 19q13.33) and one (6p21) chromosome region previously associated with PBC and PSC, respectively. The SNP, rs35730843, mapping to the POLR2G gene promoter (P = 1.2 × 10-5, OR = 0.39) demonstrated the highest effect size, and was protective for PBC, whereas for PSC respective SNPs were: rs13191240 in the intron of ADGRB3 gene (P = 0.0095, OR = 0.2) and rs3822659 (P = 0.0051, OR = 0.236) along with rs9686714 (P = 0.00077, OR = 0.2), both located in the WWC1 gene. Our cost-effective GWAS approach followed by individual genotyping confirmed several previously identified associations and discovered new susceptibility loci associated with PBC and/or PSC in Polish patients. However, further functional studies are warranted to understand the roles of these newly identified variants in the development of the two disorders.


1 December 2008
Verified
Journal Article
Closed access
JCJacek Czepiel
Jacek Czepiel
GBGrazyna Biesiada
Grazyna Biesiada
TMTomasz Mach
Tomasz Mach

1 December 2011 in Polish Archives of Internal Medicine
Verified
Journal Article
Closed access
TMTomasz Mach
Tomasz Mach
ACAndrzej Cieśla
Andrzej Cieśla
WWWioleta Warunek
Wioleta Warunek
UJUrszula Janas-Skulina
Urszula Janas-Skulina
DCDorota Cibor
Dorota Cibor
ICIrena Ciećko-Michalska
Irena Ciećko-Michalska
DOI: 10.20452/pamw.1109, Published online: December 01, 2011, Authors: Tomasz H. Mach, Andrzej Cieśla, Wioleta Warunek, Urszula Janas-Skulina, Dorota Cibor, Danuta Owczarek, Irena Ciećko-Michalska